Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Adler

Showing results (441-450 of 462) with videos related to

Pageof 47
Sort By:
The Journal of Infectious Diseases|August 7, 1999
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)S P Adler, S A Plotkin, E Gonczol, et al.
NPJ Vaccines|June 3, 2021
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trialLeike Li, Daniel C Freed, Yaping Liu, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 28, 2018
Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administrationK O Kagan, M Enders, M S Schampera, et al.
Msphere|July 7, 2021
Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic EndpointsManjula Gunawardana, Jessica Breslin, John M Cortez, et al.
Cancer Research|February 28, 2016
Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 BlockadeAlexandra Eichten, Jia Su, Alexander P Adler, et al.
Archives of Dermatology|August 24, 1999
Management of cutaneous lymphomas using a multidisciplinary approachE J Parry, S R Stevens, A C Gilliam, et al.
The Journal of Infectious Diseases|October 8, 2020
Functional Evaluation and Genetic Evolution of Human T-Cell Responses After Vaccination With a Conditionally Replication-Defective Cytomegalovirus VaccineKara S Cox, Lu Zhang, Daniel C Freed, et al.
NPJ Vaccines|December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccinationFengsheng Li, Daniel C Freed, Aimin Tang, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesLawrence M Kauvar, Keyi Liu, Minha Park, et al.
The Journal of Infectious Diseases|August 14, 2016
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative MenStuart P Adler, Anne-Marie Manganello, Ronzo Lee, et al.
Pageof 47

Showing results (441-450 of 462) with videos related to

Sort By:
Pageof 47
The Journal of Infectious Diseases|August 7, 1999
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)S P Adler, S A Plotkin, E Gonczol, et al.
NPJ Vaccines|June 3, 2021
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trialLeike Li, Daniel C Freed, Yaping Liu, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 28, 2018
Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administrationK O Kagan, M Enders, M S Schampera, et al.
Msphere|July 7, 2021
Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic EndpointsManjula Gunawardana, Jessica Breslin, John M Cortez, et al.
Cancer Research|February 28, 2016
Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 BlockadeAlexandra Eichten, Jia Su, Alexander P Adler, et al.
Archives of Dermatology|August 24, 1999
Management of cutaneous lymphomas using a multidisciplinary approachE J Parry, S R Stevens, A C Gilliam, et al.
The Journal of Infectious Diseases|October 8, 2020
Functional Evaluation and Genetic Evolution of Human T-Cell Responses After Vaccination With a Conditionally Replication-Defective Cytomegalovirus VaccineKara S Cox, Lu Zhang, Daniel C Freed, et al.
NPJ Vaccines|December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccinationFengsheng Li, Daniel C Freed, Aimin Tang, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesLawrence M Kauvar, Keyi Liu, Minha Park, et al.
The Journal of Infectious Diseases|August 14, 2016
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative MenStuart P Adler, Anne-Marie Manganello, Ronzo Lee, et al.
Pageof 47